PGI2 USE OF DIFFERENT STATISTICAL APPROACHES TO COMPARE REAL-WORLD OUTCOMES ASSOCIATED WITH VEDOLIZUMAB VERSUS INFLIXIMAB IN BIOLOGIC-NAIVE PATIENTS WITH INFLAMMATORY BOWEL DISEASE
May 1, 2019, 00:00
10.1016/j.jval.2019.04.773
https://www.valueinhealthjournal.com/article/S1098-3015(19)30965-9/fulltext
Title :
PGI2 USE OF DIFFERENT STATISTICAL APPROACHES TO COMPARE REAL-WORLD OUTCOMES ASSOCIATED WITH VEDOLIZUMAB VERSUS INFLIXIMAB IN BIOLOGIC-NAIVE PATIENTS WITH INFLAMMATORY BOWEL DISEASE
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)30965-9&doi=10.1016/j.jval.2019.04.773
First page :
Section Title :
Open access? :
No
Section Order :
10357